| Entry |
|
|---|
| Name |
Beinaglutide (INN) |
|---|
| Formula |
C149H225N39O46
|
|---|
| Exact mass |
3296.6466
|
|---|
| Mol weight |
3298.61
|
|---|
| Structure |
 |
|---|
| Sequence |
HAEGTFTSDV SSYLEGQAAK EFIAWLVKGR |
|---|
| Type |
Peptide |
|---|
| Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist |
|---|
| Comment |
Human glucagon-like peptide 1 (GLP-1) [CPD: C16048] analog
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BJ Glucagon-like peptide-1 (GLP-1) analogues
A10BJ07 Beinaglutide
D11924 Beinaglutide (INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
D11924 Beinaglutide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GLP1R
D11924 Beinaglutide (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
